V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280006492 | 280008163 | 1.7 | 90.7 | Adjuvant (A) | 2014-02-25 | 2015-04-29 | Carboplatin+Fluorouracil 4 or 5 day | 02 | N | 280019592 | PATHOS TRIAL |
| 280006493 | 280008163 | 1.75 | 72.4 | null | 2016-09-20 | 2016-09-21 | STS Rhabdomyosarcoma RMS 2005 IVA | 02 | null | 280019592 | FLUOROURACIL + MITOMYCIN + RT |
| 280006494 | 280003978 | 1.79 | 105 | Curative (C) | 2013-09-05 | 2013-09-10 | Capecitabine + Cisplatin | N | N | 280019631 | CISPLATIN + FLUOROURACIL + RT |
| 280006495 | 280008164 | 1.68 | 78.2 | Adjuvant (A) | 2015-09-08 | 2015-09-08 | VDC | 02 | N | 280019640 | TRABECTEDIN |
| 280006496 | 280003979 | 1.67 | 71.2 | Palliative (P) | 2017-03-23 | 2017-04-05 | CARBOPLATIN + FLUOROURACIL | 2 | N | 280019697 | DOXORUBICIN + OLARATUMAB |
| 280006497 | 280003980 | 1.97 | 0 | Palliative (P) | 2017-04-05 | 2017-12-15 | Carboplatin+Fluorouracil 4 or 5 day | 02 | N | 280019728 | GEMCARBO |
| 280006498 | 280003980 | 1.54 | 55.1 | Palliative (P) | 2016-07-04 | 2016-07-31 | Carbo F | 2 | N | 280019728 | CARBO + FLUOROURACIL |
| 280006499 | 280003981 | null | 116.8 | Palliative (P) | 2016-04-20 | 2016-04-21 | Paclitaxel 7 day | N | null | 280019814 | DOXORUBICIN + OLARATUMAB |
| 280006500 | 280003982 | 1.53 | null | Palliative (P) | 2017-03-07 | 2017-03-23 | OCTREOTIDE | N | N | 280019820 | GEMCARBO |
| 280006501 | 280003983 | 1.48 | 86 | Not known (9) | 2017-03-25 | 2017-03-26 | Ipilimumab | N | N | 280019828 | TCF |
| 280006502 | 280003983 | 1.75 | 77.5 | Curative (C) | 2016-05-22 | 2016-05-31 | Capecitabine | Y | Y | 280019828 | TCF |
| 280006503 | 280003984 | 1.6 | 72.5 | Palliative (P) | 2014-01-27 | 2014-02-03 | Oxaliplatin + Modified de Gramont | 02 | N | 280019933 | IVA |
| 280006504 | 280003984 | 1.81 | 99 | Curative (C) | 2013-06-22 | 2013-06-25 | Cisplatin + Topotecan | 02 | null | 280019933 | DE-ESCALATE TRIAL |
| 280006505 | 280003985 | null | 66.8 | Curative (C) | 2017-06-26 | 2017-06-29 | FEC | Y | N | 280019953 | CISPLATIN + FLUOROURACIL + RT |
| 280006506 | 280003985 | 1.6 | 57 | Palliative (P) | 2014-08-18 | 2014-08-19 | Methotrexate + Vinblastine | 02 | N | 280019953 | DOCETAXEL + GEMCITABINE |
| 280006507 | 280003985 | 1.61 | 90.3 | Curative (C) | 2015-09-01 | 2015-09-03 | UKALL14- Cons Cycle 1 | 2 | N | 280019953 | IVADO |
| 280006508 | 280003986 | 1.7 | null | Palliative (P) | 2017-05-24 | 2017-05-26 | Carboplatin+Fluorouracil 4 or 5 day | 02 | N | 280020025 | CAPECITABINE + CARBOPLATIN |
| 280006509 | 280003987 | null | 92.5 | Palliative (P) | 2015-02-17 | 2015-02-17 | FLUOROURACIL + MITOMYCIN + RT | N | N | 280020052 | DOXORUBICIN + OLARATUMAB |
| 280006510 | 280003988 | 1.7 | 65.2 | Palliative (P) | 2016-08-15 | 2016-08-15 | VIDE | 2 | N | 280020080 | DOXORUBICIN + OLARATUMAB |
| 280006511 | 280003989 | 1.7 | 66.85 | Curative (C) | 2015-09-01 | 2015-09-01 | CARBOPLATIN + FLUOROURACIL | N | null | 280020096 | EURO-EWING |
| 280006512 | 280003990 | null | 10.55 | Curative (C) | 2014-06-11 | 2014-06-26 | Cisplatin + Fluorouracil + RT 5day | 02 | Y | 280020109 | COMPARE TRIAL |
| 280006513 | 280003991 | 1.64 | 73.2 | Adjuvant (A) | 2018-06-23 | 2018-07-14 | CARBOPLATIN + FLUOROURACIL | 02 | N | 280020201 | MITOMYCIN INTRAVESICULAR |
| 280006514 | 280003991 | null | null | Neo-adjuvant (N) | 2017-10-18 | 2017-10-18 | Capecitabine | N | null | 280020201 | CARBOPLATIN + DOCETAXEL + FLUOROURACIL |
| 280006515 | 280010141 | 1.46 | null | Palliative (P) | 2016-12-13 | 2016-12-20 | Carboplatin + Pemetrexed | 02 | N | 280020288 | CEDIRANIB |
| 280006516 | 280010141 | 1.76 | 80 | Palliative (P) | 2014-04-10 | 2014-04-11 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 2 | N | 280020288 | IVADO |
| 280006517 | 280010141 | 1.57 | 83.2 | Neo-adjuvant (N) | 2014-10-14 | 2014-10-24 | STS Rhabdomyosarcoma RMS 2005 IVADo | N | N | 280020288 | GEMCARBO |
| 280006518 | 280003992 | null | 52.35 | null | 2018-11-28 | 2018-11-28 | GemCarbo Days 1+8 | N | null | 280020346 | VIDE |
| 280006519 | 280003993 | 1.58 | 47.5 | Palliative (P) | 2016-06-29 | 2016-07-02 | CEDIRANIB | 2 | N | 280020392 | CETUXIMAB + CISPLATIN + FU |
| 280006520 | 280003994 | 1.72 | null | Palliative (P) | 2014-12-09 | 2015-02-03 | MELPHALAN | null | null | 280020402 | IMATINIB |
| 280006521 | 280003994 | 1.61 | 70.6 | Curative (C) | 2018-01-18 | 2018-01-18 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | N | 280020402 | IVADO |
| 280006522 | 280003995 | 1.7 | 72.15 | Neo-adjuvant (N) | 2015-04-17 | 2015-05-07 | CARBOPLATIN + VINORELBINE | 02 | N | 280020449 | BCG |
| 280006523 | 280003996 | 1.69 | 90.3 | Palliative (P) | 2017-06-03 | 2017-06-03 | Oxaliplatin + Modified de Gramont | N | N | 280020488 | CETUXIMAB + CISPLATIN + FU |
| 280006524 | 280003997 | 1.67 | 107.4 | Neo-adjuvant (N) | null | 2013-04-21 | CARBOPLATIN + GEMCITABINE | N | N | 280020492 | CISPLATIN + FLUOROURACIL + RT |
| 280006525 | 280008171 | null | null | Neo-adjuvant (N) | 2014-06-25 | 2014-06-29 | Trabectedin | 02 | Y | 280020538 | VIDE |
| 280006526 | 280003998 | 1.78 | 70.5 | Palliative (P) | 2017-03-20 | 2017-04-06 | STS Rhabdo RMS 2005 Vin Cyclo | N | Y | 280020554 | CETUXIMAB + CISPLATIN + FU |
| 280006527 | 280003998 | 1.85 | null | Adjuvant (A) | 2015-03-14 | 2015-03-21 | Cisplatin + Vinorelbine (IV) | N | N | 280020554 | CISPLATIN + DOXORUBICIN |
| 280006528 | 280003999 | 1.7 | 80.6 | Neo-adjuvant (N) | null | 2013-10-20 | STS Rhabdomyosarcoma RMS 2005 IVA | null | null | 280020622 | EURO-EWING |
| 280006529 | 280004000 | null | null | Neo-adjuvant (N) | 2015-07-07 | 2015-07-07 | IPILIMUMAB + NIVOLUMAB | N | N | 280020664 | EURO-EWING |
| 280006530 | 280004000 | 0 | 108.9 | Palliative (P) | null | 2017-09-26 | Cisplatin + Fluorouracil + RT 5day | null | null | 280020664 | DOCETAXEL + GEMCITABINE |
| 280006531 | 280004001 | 1.83 | 81.1 | Palliative (P) | 2014-05-01 | 2014-06-01 | Ifosfamide | 02 | Y | 280020676 | LIPOSOMAL DOXORUBICIN |
| 280006532 | 280004002 | 1.73 | 72 | null | 2016-04-08 | 2016-05-10 | VINCRISTINE | 2 | 2 | 280020683 | CYCLOPHOSPHAMIDE + DACTINOMYCIN + VINCRISTINE |
| 280006533 | 280004003 | 1.6 | 83.9 | Curative (C) | 2019-01-01 | 2019-01-01 | Docetaxel+Gemcitabine (no prior RT) | N | null | 280020845 | EURO-EWING |
| 280006534 | 280004004 | 1.75 | 74 | Palliative (P) | 2014-05-16 | 2014-05-17 | Trabectedin | 02 | null | 280020851 | IRINOTECAN + MDG |
| 280006535 | 280004005 | 1.73 | null | null | 2018-06-20 | 2018-06-21 | AC | N | N | 280020922 | FLUOROURACIL + MITOMYCIN + RT |
| 280006536 | 280004005 | null | null | null | null | 2018-03-14 | Oxaliplatin + Modified de Gramont | null | null | 280020922 | CARBO + FLUOROURACIL |
| 280006537 | 280004006 | 1.74 | 86 | Palliative (P) | 2018-01-30 | 2018-02-05 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 02 | N | 280020985 | PACLITAXEL |
| 280006538 | 280004006 | null | null | Adjuvant (A) | 2015-03-20 | 2015-04-11 | Carbo F | N | N | 280020985 | TOPOTECAN |
| 280006539 | 280004006 | 1.73 | 65 | Palliative (P) | 2016-01-29 | 2016-01-29 | CAPECITABINE + OXALIPLATIN | 02 | N | 280020985 | CYCLOPHOSPHAMIDE + TOPOTECAN |
| 280006540 | 280004006 | 1.75 | 76 | Curative (C) | 2018-12-28 | 2019-01-01 | Doxorubicin + Olaratumab | N | N | 280020985 | RMS 2005 TRIAL |
| 280006541 | 280004007 | 1.72 | 71 | Palliative (P) | 2015-10-23 | 2015-10-24 | PEMBROLIZUMAB | 02 | N | 280021107 | TEMOZOLOMIDE |